Core Viewpoint - Meihua Medical's stock price has shown significant volatility, with a year-to-date increase of 55.59% but a recent decline of 9.96% over the past five trading days [2]. Group 1: Stock Performance - As of January 14, Meihua Medical's stock price was 37.42 CNY per share, with a market capitalization of 21.287 billion CNY [1]. - The stock has experienced a 77.68% increase over the past 20 days and a 67.58% increase over the past 60 days [2]. - The company has appeared on the "Dragon and Tiger List" twice this year, with the latest instance on January 7, where it recorded a net buy of -71.9649 million CNY [2]. Group 2: Financial Performance - For the period from January to September 2025, Meihua Medical reported a revenue of 1.194 billion CNY, reflecting a year-on-year growth of 3.28%, while the net profit attributable to shareholders decreased by 19.25% to 208 million CNY [3]. Group 3: Shareholder Information - As of December 19, the number of shareholders for Meihua Medical was 15,300, a decrease of 1.74% from the previous period, with an average of 24,335 circulating shares per shareholder, an increase of 1.77% [3]. - The company has distributed a total of 293 million CNY in dividends since its A-share listing [4]. - Notable institutional shareholders include Guotai Junan's value advantage flexible allocation fund and Huabao's medical ETF, with changes in their holdings noted [4].
美好医疗涨2.02%，成交额4.53亿元，主力资金净流出1753.69万元